Pharma marketed antidepressants to children after hiding the risk of suicide and aggression revealed by clinical trials

Tuesday, March 1, 2016
By Paul Martin

by: Evelyn Pringle
NaturalNews.com
Tuesday, March 01, 2016

A BMJ press release reported, “Children and adolescents have a doubled risk of aggression and suicide when taking one of the five most commonly prescribed antidepressants,” according to a study published in The BMJ on January 28, 2016.

Selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs) are the most commonly prescribed antidepressants, the release notes.

Researchers from the Nordic Cochrane Centre in Denmark carried out a systematic review and meta-analysis of 68 clinical study reports of 70 trials involving 18,526 patients to examine use of antidepressants and associated serious harms, including “deaths, suicidal thoughts and attempts as well as aggression and akathisia, a form of restlessness that may increase suicide and violence.”

But “because of the poor design of clinical trials that assess these antidepressants, and the misreporting of findings in published articles,” the experts report, “the true risk for all associated serious harms—such as deaths, aggression, akathisia and suicidal thoughts and attempts—remains unknown for children, adolescents and adults.”

The researchers examined “trials that contained patient narratives or individual patient listings of associated harms,” the authors explained, that “are often not included in published trial reports.” They also “analysed clinical study reports, prepared by pharmaceutical companies for market authorisation, and summary trial reports, both of which usually include more information.”

The Rest…HERE

Leave a Reply

Join the revolution in 2018. Revolution Radio is 100% volunteer ran. Any contributions are greatly appreciated. God bless!

Follow us on Twitter